These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12126717)

  • 41. Neuraminidase inhibitors: progress in the management of influenza.
    Woodhead M; Lavanchy D; Johnston S; Colman P; Fleming D
    Int J Clin Pract; 2000 Nov; 54(9):604-10. PubMed ID: 11220989
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recent progress and challenges in the discovery of new neuraminidase inhibitors.
    Chamni S; De-Eknamkul W
    Expert Opin Ther Pat; 2013 Apr; 23(4):409-23. PubMed ID: 23369206
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuraminidase inhibitors for treatment of influenza A and B infections.
    MMWR Recomm Rep; 1999 Dec; 48(RR-14):1-9. PubMed ID: 10632443
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Neuraminidase inhibitors oseltamivir and zanamivir: new means of defence against influenza].
    de Jong JC; Beyer WE; Rimmelzwaan GF; Fouchier RA; Osterhaus AD
    Ned Tijdschr Geneeskd; 2004 Jan; 148(2):73-9. PubMed ID: 14753128
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antivirals for influenza in healthy adults: systematic review.
    Jefferson T; Demicheli V; Rivetti D; Jones M; Di Pietrantonj C; Rivetti A
    Lancet; 2006 Jan; 367(9507):303-13. PubMed ID: 16443037
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bedside rapid flu test and zanamivir prescription in healthy working adults: a cost-benefit analysis.
    Schwarzinger M; Housset B; Carrat F
    Pharmacoeconomics; 2003; 21(3):215-24. PubMed ID: 12558471
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The smaller number of influenza patients with neuropsychiatric events had taken oseltamivir beforehand].
    Tomono N; Shiro H
    Kansenshogaku Zasshi; 2008 Nov; 82(6):613-8. PubMed ID: 19086415
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outcomes and Susceptibility to Neuraminidase Inhibitors in Individuals Infected With Different Influenza B Lineages: The Influenza Resistance Information Study.
    van der Vries E; Ip DK; Cowling BJ; Zhang JD; Tong X; Wojtowicz K; Schutten M; Boucher CA
    J Infect Dis; 2016 Jan; 213(2):183-90. PubMed ID: 26160744
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinicians' attitude towards a placebo-controlled randomised clinical trial investigating the effect of neuraminidase inhibitors in adults hospitalised with influenza.
    Bradbury N; Nguyen-Van-Tam J; Lim WS
    BMC Health Serv Res; 2018 May; 18(1):311. PubMed ID: 29716584
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neuraminidase inhibitor therapy in a military population.
    Fairchok MP; Chen WJ; Arnold JC; Schofield C; Danaher PJ; McDonough EA; Ottolini M; Mor D; Ridore M; Burgess TH; Millar EV
    J Clin Virol; 2015 Jun; 67():17-22. PubMed ID: 25959151
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Advances in the structure-based design of the influenza A neuraminidase inhibitors.
    Mitrasinovic PM
    Curr Drug Targets; 2010 Mar; 11(3):315-26. PubMed ID: 20210756
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vaccines and therapeutics against influenza virus infections.
    Saito T; Tashiro M
    Pediatr Int; 2000 Apr; 42(2):219-25. PubMed ID: 10804745
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antivirals for influenza: historical perspectives and lessons learned.
    Hayden FG
    Antiviral Res; 2006 Sep; 71(2-3):372-8. PubMed ID: 16815563
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuraminidase inhibitors in the management of influenza--experience of an outpatient practice.
    Vogel GE
    Med Microbiol Immunol; 2002 Dec; 191(3-4):161-3. PubMed ID: 12458352
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Economic analysis of influenza vaccination and antiviral treatment for healthy working adults.
    Lee PY; Matchar DB; Clements DA; Huber J; Hamilton JD; Peterson ED
    Ann Intern Med; 2002 Aug; 137(4):225-31. PubMed ID: 12186512
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-influenza drugs and neuraminidase inhibitors.
    Roberts NA
    Prog Drug Res; 2001; Spec No():35-77. PubMed ID: 11548210
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influenza.
    Stamboulian D; Bonvehí PE; Nacinovich FM; Cox N
    Infect Dis Clin North Am; 2000 Mar; 14(1):141-66. PubMed ID: 10738677
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neuraminidase inhibitors for influenza A and B: antivirals need to be protected from adverse conditions to retain effectiveness.
    Arya SC; Agarwal N
    BMJ; 2003 Jul; 327(7406):105-6. PubMed ID: 12855538
    [No Abstract]   [Full Text] [Related]  

  • 59. RWJ-270201 (BCX-1812): a novel neuraminidase inhibitor for influenza.
    Young D; Fowler C; Bush K
    Philos Trans R Soc Lond B Biol Sci; 2001 Dec; 356(1416):1905-13. PubMed ID: 11779391
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Optimizing antiviral therapy for influenza: understanding the evidence.
    Ison MG
    Expert Rev Anti Infect Ther; 2015 Apr; 13(4):417-25. PubMed ID: 25695406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.